ATHA - Athira Pharma, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - ATHA (1620463)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
26 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

A
2024-01-05
ATHALenington RachelCOO, CDOS - Sale$2.91-2,41213,395-15%-$7,019
A
2024-01-05
ATHALitton Mark JamesCEOS - Sale$2.91-4,820164,086-3%-$14,026
A
2024-01-05
ATHAWorthington MarkGCS - Sale$2.91-2,41234,452-7%-$7,019
A
2024-01-05
ATHAGengos AndrewCFO, CHIEF BUSINESS OFFICERS - Sale$2.91-1,20883,804-1%-$3,515
A
2024-01-05
ATHAChurch KevinChief Scientific OfficerS - Sale$2.91-2,41280,256-3%-$7,019
2023-01-05
ATHAGengos AndrewSee BelowS - Sale$2.91-1,20883,804-1%-$3,515
2024-01-05
ATHALitton Mark JamesCEOS - Sale$2.91-4,820164,086-3%-$14,026
2024-01-05
ATHAWorthington MarkGCS - Sale$2.91-2,41234,452-7%-$7,019
2023-01-05
ATHAChurch KevinChief Scientific OfficerS - Sale$2.91-2,41280,256-3%-$7,019
2024-01-05
ATHALenington RachelCOOS - Sale$2.91-2,41213,395-15%-$7,019
M
2023-12-27
ATHAPerceptive Advisors LLCDir, 10%P - Purchase$2.42+605,6865,402,964+13%+$1,462,895
2023-06-07
ATHAGengos AndrewSee BelowP - Purchase$3.43+15,00080,012+23%+$51,445
M
2023-06-02
ATHAGengos AndrewSee BelowP - Purchase$2.95+65,01265,012New+$191,572
M
2023-03-29
ATHAPickering GrantDirP - Purchase$2.41+25,00025,783>999%+$60,350
2023-03-29
ATHAJohnson James ADirP - Purchase$2.40+5,0005,000New+$12,000
2022-12-28
ATHAMileson GlennaCFOP - Purchase$2.85+50,000159,930+45%+$142,250
2022-12-02
ATHARomano Kelly ADirP - Purchase$3.29+30,00038,315+361%+$98,700
2022-11-15
ATHAMoebius HansChief Medical OfficerP - Purchase$3.29+5,00065,836+8%+$16,442
M
2022-06-29
ATHAPerceptive Advisors LLCDir, 10%P - Purchase$2.99+1,371,3624,797,278+40%+$4,100,372
2022-06-28
ATHAMoebius HansChief Medical OfficerP - Purchase$2.88+10,00052,955+23%+$28,800
2022-06-23
ATHAWorthington MarkGCS - Sale$2.69-2,61419,097-12%-$7,032
2022-06-23
ATHAMileson GlennaCFOS - Sale$2.69-2,614109,167-2%-$7,032
2022-06-23
ATHALitton Mark JamesCEOS - Sale$2.69-7,960148,244-5%-$21,412
2022-06-23
ATHALenington RachelCOOS - Sale$2.69-4,1935,807-42%-$11,279
2022-06-23
ATHAChurch KevinEVP, ResearchS - Sale$2.69-2,61457,695-4%-$7,032
2022-03-31
ATHARomano Kelly ADirP - Purchase$13.11+8,0008,315>999%+$104,880

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top